$ENTA ENANTA PHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENANTA PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ENANTA PHARMACEUTICALS INC for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ENTA
Company Address: 500 ARSENAL STREET WATERTOWN 02472
Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
Market Capitalization: $593.41M
Prev close: $32.20
Average Daily Volume: 244,274
Days Low: $30.69
Year Low: $20.79
Year High: $37.31
ENANTA PHARMACEUTICALS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | Russell Lesley | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | Peterson Kristine | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 11.77 | 4,872 | 57,343 | 0 | |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 11.77 | 3,672 | 43,219 | 0 | |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 14.18 | 5,149 | 73,013 | 0 | |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 11.77 | 4,872 | 57,343 | 330,918 | 326 K to 330.9 K (+1.49 %) |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 11.77 | 3,672 | 43,219 | 326,046 | 322.4 K to 326 K (+1.14 %) |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 14.18 | 5,149 | 73,013 | 322,374 | 317.2 K to 322.4 K (+1.62 %) |
| Jan 27 2021 | ENTA | ENANTA PHARMACEUTI ... | Luu Brendan | Sr. VP, Business De ... | Option Exercise | A | 48.03 | 75,000 | 3,602,250 | 75,000 | |
| Jan 08 2021 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 45.58 | 6,000 | 273,463 | 61,759 | 67.8 K to 61.8 K (-8.85 %) |
| Jan 08 2021 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 45.58 | 6,000 | 273,463 | 61,759 | 67.8 K to 61.8 K (-8.85 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 0.00 | 5,250 | 0 | 0 |